Correlation Between Vaccinex and Climb Bio
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Climb Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Climb Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Climb Bio, you can compare the effects of market volatilities on Vaccinex and Climb Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Climb Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Climb Bio.
Diversification Opportunities for Vaccinex and Climb Bio
Pay attention - limited upside
The 3 months correlation between Vaccinex and Climb is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Climb Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Climb Bio and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Climb Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Climb Bio has no effect on the direction of Vaccinex i.e., Vaccinex and Climb Bio go up and down completely randomly.
Pair Corralation between Vaccinex and Climb Bio
Given the investment horizon of 90 days Vaccinex is expected to generate 2.3 times more return on investment than Climb Bio. However, Vaccinex is 2.3 times more volatile than Climb Bio. It trades about -0.02 of its potential returns per unit of risk. Climb Bio is currently generating about -0.22 per unit of risk. If you would invest 240.00 in Vaccinex on October 6, 2024 and sell it today you would lose (131.00) from holding Vaccinex or give up 54.58% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 95.16% |
Values | Daily Returns |
Vaccinex vs. Climb Bio
Performance |
Timeline |
Vaccinex |
Climb Bio |
Vaccinex and Climb Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vaccinex and Climb Bio
The main advantage of trading using opposite Vaccinex and Climb Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Climb Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Climb Bio will offset losses from the drop in Climb Bio's long position.Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
Climb Bio vs. Vaccinex | Climb Bio vs. Vigil Neuroscience | Climb Bio vs. Viracta Therapeutics | Climb Bio vs. Dogwood Therapeutics, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |